Similarly, Delkhah26 identified FEZ1 as a potential non-invasive blood biomarker for IBD through transcriptomic analyses, highlighting the role of autophagy in disease pathogenesis. This evidence concerns the gene FEZ1 and irritable bowel syndrome.